Handelsavisen
prelaunch
76
7698.T Tokyo Stock Exchange Food Retail & Distribution

7698.T

¥2 450,00
Open in Charts → Attach watcher ⌖
JPY
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,81 %
Op margin
1,1 %
ROE
12,6 %
Net margin
0,9 %
Debt / equity
0,64
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

The company operates in the Food & Drug Retailing industry, generating revenue primarily through the sale of groceries and pharmaceutical products to consumers.

Business. The company operates in the Food & Drug Retailing industry, generating revenue primarily through the sale of groceries and pharmaceutical products to consumers.

Classification92 %
SectorConsumer Non-Cyclicals
Business sectorFood & Drug Retailing
IndustryFood Retail & Distribution
ActivityFood & Drug Retailing
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
12,6 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 7698.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples · THIS SECTOR−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 7698.T. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    The company operates in the Food & Drug Retailing industry, generating revenue primarily through the sale of groceries and pharmaceutical products to consumers.

    Classification92 %
    SectorConsumer Non-Cyclicals
    Business sectorFood & Drug Retailing
    IndustryFood Retail & Distribution
    ActivityFood & Drug Retailing
    AI synthesis
    GENERATED

    The company maintains a debt-to-equity ratio of 0.64, indicating a moderate reliance on debt financing, and a current ratio of 0.94, suggesting limited short-term liquidity cushion. With cash and equivalents of ¥1.47 billion and long-term debt of ¥2.47 billion, the company has negative net cash, which raises concerns about liquidity risk. The return on equity of 12.55% is strong, but the return on assets of 2.77% is relatively low, indicating that the company is not efficiently utilizing its asset base to generate returns.

    Profitability is driven by a gross profit of ¥9.57 billion and operating income of ¥628 million, but the net income of ¥482 million is modest relative to revenue of ¥54.72 billion. This suggests that the company is facing significant operating expenses or cost pressures. The company's operating cash flow of ¥179 million and free cash flow of ¥51 million are both positive but low, which may limit its ability to reinvest in growth or pay dividends.

    The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic downturns or supply chain disruptions. The capital expenditure of ¥740 million is significant, indicating ongoing investment in infrastructure or store expansion, but the source of funding is not disclosed.

    Looking ahead, the company is expected to maintain a stable revenue trajectory, with no significant growth or decline projected in the next fiscal year. The operating income is expected to remain flat, and the net income is expected to decline slightly. The company's risk assessment indicates a medium liquidity risk and a low dilution risk, but the negative net cash position is a key flag.

    Recent filings and transcripts do not disclose any material events that would significantly impact the company's financial position or strategic direction. The company's risk factors include supply chain volatility and competitive pressures in the retail sector.

    Key takeaways
    • The company has a strong return on equity but a weak return on assets, indicating inefficiencies in asset utilization.
    • The company's liquidity position is weak, with a current ratio below 1 and negative net cash.
    • The company's profitability is modest, with a low net income margin and significant operating expenses.
    • The company's capital expenditure is substantial, but the source of funding is not disclosed.
    • The company's risk assessment indicates a medium liquidity risk and a low dilution risk.
    • "margin_outlook_rationale": "The company's gross margin is expected to remain stable, driven by consistent pricing and cost management.",

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    ¥2 450,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    ¥3.84B
    Net cash
    -¥1.00B
    Current ratio
    0.9
    Debt / equity
    0.6
    ROA
    2.8%
    ROE
    12.6%
    Cash conversion
    37.0%
    CapEx / revenue
    -1.4%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin1,1 %Below median
    Net Margin0,9 %Below median
    ROE12,6 %Above median
    Capex / Rev-1,4 %Above median
    D/E0,64Below median
    Cash Conv0,37Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • 7698.T Market data — financials · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    7698.TCanonical
    Tokyo Stock Exchange · JPY

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage